Boxer Capital, LLC

This profile gathers the share dealings of Boxer Capital, LLC across 6 companies, led by Tango Therapeutics, Inc., iTeos Therapeutics, Inc. and Mirati Therapeutics, Inc. The record holds 21 filings, for trades running from 14 January 2016 to 10 May 2024.

In open-market terms, that means 8 purchases worth €17.3M on one side and 7 sales worth €40.0M on the other. Taken together, the sales exceed the purchases by €22.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants.

Half of the purchases are above €1.5M and half below. On 1 out of 6 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 80% of cases; the median change was +45.5%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 14 May 2024, the filings show a share grant worth €18.5M in iTeos Therapeutics, Inc. The clock since the last published purchase (17 October 2023) now reads 1,097 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.